{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:49:36Z","timestamp":1789879776571,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.jbspin.2006.02.010","type":"journal-article","created":{"date-parts":[[2006,8,31]],"date-time":"2006-08-31T12:52:32Z","timestamp":1157028752000},"page":"710-713","source":"Crossref","is-referenced-by-count":142,"title":["Vasculitides induced by\u00a0TNF\u03b1 antagonists: a\u00a0study in\u00a039\u00a0patients in\u00a0France"],"prefix":"10.1016","volume":"73","author":[{"given":"Bernadette","family":"Saint Marcoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"De Bandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2006.02.010_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00004836-200305000-00010","article-title":"Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab","volume":"36","author":"McIlwain","year":"2003","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jbspin.2006.02.010_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/rheumatology\/41.1.116","article-title":"Etanercept and infliximab associated with cutaneous vasculitis","volume":"41","author":"McCain","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.02.010_bib3","first-page":"1955","article-title":"Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents","volume":"31","author":"Mohan","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.02.010_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3083.2005.01570.x","article-title":"Immunology of cutaneous vasculitis associated with both etanercept and infliximab","volume":"61","author":"Srivastava","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jbspin.2006.02.010_bib5","first-page":"740","article-title":"Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept","volume":"32","author":"Mor","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.02.010_bib6","first-page":"2287","article-title":"Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series","volume":"30","author":"Jarrett","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.02.010_bib7","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/rheumatology\/41.12.1450","article-title":"Anti-tumour necrosis factor therapy associated with cutaneous vasculitis","volume":"41","author":"Livermore","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.02.010_bib8","first-page":"1885","article-title":"Tumor necrosis factor-a blockade and the risk of vasculitis","volume":"31","author":"Guillevin","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.02.010_bib9","first-page":"2079","article-title":"Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for RA","volume":"31","author":"Richette","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.02.010_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/rheumatology\/41.6.703","article-title":"Lethal medium-vessel panarteritis mimicking deep sepsis following etanercept and minocycline therapy in a patient with severe rheumatoid arthritis","volume":"41","author":"Berthelot","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.02.010_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jbspin.2004.05.008","article-title":"Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNF alpha agent etanercept for rheumatoid arthritis","volume":"71","author":"Roux","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2006.02.010_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2006.02.010_bib13","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/art.20300","article-title":"Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis","volume":"50","author":"Hoffman","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.02.010_bib14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/41.11.1303","article-title":"Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis","volume":"41","author":"Lamprecht","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.02.010_bib15","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.02.010_bib16","first-page":"726","article-title":"B cell activation in rheumatoid arthritis patients under infliximab treatment","volume":"21","author":"De Miguel","year":"2003","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X06001849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X06001849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T18:28:48Z","timestamp":1547404128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X06001849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S1297319X06001849"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2006.02.010","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}